Furthermore, the transcriptional levels of FCER1G and SPI1 can also distinguish the OS patients into two clusters with different prognosis and immune cell infiltrations, suggesting a potential treatment target for OS and other TYROBP-associated cancers. This evidence concerns the gene SPI1 and cancer.